{"title":"更正“咪唑喹诺啉衍生物EAPB0503：一种靶向突变核磷蛋白1治疗急性髓系白血病的有前途的药物”。","authors":"","doi":"10.1002/cncr.70347","DOIUrl":null,"url":null,"abstract":"<p>Nabbouh AI, Hleihel RS, Saliba JL, et al. Imidazoquinoxaline derivative EAPB0503: a promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia. <i>Cancer</i>. 2017;123(9):1662-1673. doi:10.1002/cncr.30515</p><p>In the published article, the GAPDH blots for the KG-1α and MOLM13 extracts in Figure 2E were inaccurately presented due to inadvertent errors during figure preparation. The correct Figure 2 is provided below.</p><p>Figure 2. Corrected.</p><p></p><p>The legend for Figure 2 has also been updated (changes in bold) to clarify that the same GAPDH blots for the OCI-AML3 extracts were used in Figures 2E and 2G:</p><p>Furthermore, the loading controls for the KG-1α and MOLM13 extracts in Figure 3A were inaccurately labelled as “Actin” instead of “GAPDH”. The correct Figure 3 is provided below.</p><p>Figure 3. Corrected.</p><p></p><p>The authors apologize for these errors and for the inconvenience they may have caused.</p>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"132 6","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70347","citationCount":"0","resultStr":"{\"title\":\"Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”\",\"authors\":\"\",\"doi\":\"10.1002/cncr.70347\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Nabbouh AI, Hleihel RS, Saliba JL, et al. Imidazoquinoxaline derivative EAPB0503: a promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia. <i>Cancer</i>. 2017;123(9):1662-1673. doi:10.1002/cncr.30515</p><p>In the published article, the GAPDH blots for the KG-1α and MOLM13 extracts in Figure 2E were inaccurately presented due to inadvertent errors during figure preparation. The correct Figure 2 is provided below.</p><p>Figure 2. Corrected.</p><p></p><p>The legend for Figure 2 has also been updated (changes in bold) to clarify that the same GAPDH blots for the OCI-AML3 extracts were used in Figures 2E and 2G:</p><p>Furthermore, the loading controls for the KG-1α and MOLM13 extracts in Figure 3A were inaccurately labelled as “Actin” instead of “GAPDH”. The correct Figure 3 is provided below.</p><p>Figure 3. Corrected.</p><p></p><p>The authors apologize for these errors and for the inconvenience they may have caused.</p>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"132 6\",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2026-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70347\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70347\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70347","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”
Nabbouh AI, Hleihel RS, Saliba JL, et al. Imidazoquinoxaline derivative EAPB0503: a promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia. Cancer. 2017;123(9):1662-1673. doi:10.1002/cncr.30515
In the published article, the GAPDH blots for the KG-1α and MOLM13 extracts in Figure 2E were inaccurately presented due to inadvertent errors during figure preparation. The correct Figure 2 is provided below.
Figure 2. Corrected.
The legend for Figure 2 has also been updated (changes in bold) to clarify that the same GAPDH blots for the OCI-AML3 extracts were used in Figures 2E and 2G:
Furthermore, the loading controls for the KG-1α and MOLM13 extracts in Figure 3A were inaccurately labelled as “Actin” instead of “GAPDH”. The correct Figure 3 is provided below.
Figure 3. Corrected.
The authors apologize for these errors and for the inconvenience they may have caused.
期刊介绍：
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society.
CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
